| 1. |
Rabe KF，Hurd S，Anzueto A，et al.Global strategy for the diagnosis，management，and prevention of chronic obstructive pulmonary disease：GOLD executive summary.Am J Respir Crit Care Med，2007，176：532-555.
|
| 2. |
Seemungal TA，Donaldson GC，Bhowmik A，et al.Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease.Am J Respir Crit Care Med，2000，161：1608-1613.
|
| 3. |
O’Donnell DE，Parker CM.COPD exacerbations 3：Pathophysiology.Thorax，2006，61：354-361.
|
| 4. |
Perera WR，Hurst JR，Wilkinson TM，et al.Inflammatory changes，recovery and recurrence at COPD exacerbation.Eur Respir J，2007，29：527-534.
|
| 5. |
Seemungal T，Harper-Owen R，Bhowmik A，et al.Respiratory viruses，symptoms，and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease.Am J Respir Crit Care Med，2001，164：1618-1623.
|
| 6. |
Hurst JR，Wilkinson TM，Perera WR，et al.Relationships among bacteria，upper airway，lower airway，and systemic inflammation in COPD.Chest，2005，127：1219-1226.
|
| 7. |
Ram FSF，Rodriguez-Roisin R，Granado-Navarrete A，et al.Antibiotics for exacerbation of chronic obstructive pulmonary disease.Cochrane Database Syst Rev，2006，2：CD004403.
|
| 8. |
Calverley PM，Anderson JA，Celli B，et al.Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease.N Engl J Med，2007，356：775-789.
|
| 9. |
Calverley PM，Boonsawat W，Cseke Z，et al.Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease.Eur Respir J，2003，22：912-919.
|
| 10. |
Casanova C，Celli BR，Tost L，et al.Long-term controlled trial of nocturnal nasal positive pressure ventilation in patients with severe COPD.Chest，2000，118：1582-1590.
|
